Sandu Pharmaceuticals Ltd announces demise of Managing Director and Promoter Shri Umesh Sandu
Sandu Pharmaceuticals Ltd has announced the sudden and untimely demise of its Managing Director and Promoter, Shri Umesh Sandu. The company reported that he passed away on Friday, June 19, 2026.The passing of Shri Umesh Sandu is considered an irreparable loss to the company. Management conveyed deep sympathy and sorrow to his family members. During his tenure with the organization, Shri Sandu contributed significantly through his vision and active participation in various Board Meetings and Committee Meetings. Following his demise, he ceases to be a member of both the Audit Committee and the Stakeholders Relationship Committee.
The details regarding the change in directorship are as follows:
| Detail | Information |
|---|---|
| Name of Director | Shri Umesh Sandu |
| Designation | Managing Director/Promoter |
| Reason for Change | Death |
| Date of Cessation | June 19, 2026 (8:30 am) |
| Shares Held in Company | 13,88,693 |
Stock Price Movement
Sandu Pharmaceuticals Ltd settled at ₹42.77 on Friday, edging up 1.30% in after-hours trading. The shares traded within an intraday range spanning from a low of ₹42.35 to a high of ₹43.99.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.